Jason Nascone, MD | |
22 S Greene St, Baltimore, MD 21201-1544 | |
(410) 448-6332 | |
(410) 448-6296 |
Full Name | Jason Nascone |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 30 Years |
Location | 22 S Greene St, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689625683 | NPI | - | NPPES |
1689625683 | Other | MD | NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | D55465 (Maryland) | Secondary |
207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | D0055465 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Maryland Medical Center | Baltimore, MD | Hospital |
University Of Md Medical Center Midtown Campus | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Maryland Orthopaedic Trauma Associates, P.a. | 5294621025 | 35 |
News Archive
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Resident physicians' participation in a brief training program designed to increase empathy with their patients produced significant improvement in how patients perceived their interactions with the residents.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
Addicts, even those who have been abstinent for long periods of time, are often still vulnerable to their own memories of prior drug use.
› Verified 4 days ago
Entity Name | University Of Maryland Orthopaedic Trauma Associates, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497708051 PECOS PAC ID: 5294621025 Enrollment ID: O20040227000265 |
News Archive
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Resident physicians' participation in a brief training program designed to increase empathy with their patients produced significant improvement in how patients perceived their interactions with the residents.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
Addicts, even those who have been abstinent for long periods of time, are often still vulnerable to their own memories of prior drug use.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Jason Nascone, MD Po Box 64881, Baltimore, MD 21264-4881 Ph: (410) 448-6332 | Jason Nascone, MD 22 S Greene St, Baltimore, MD 21201-1544 Ph: (410) 448-6332 |
News Archive
NexMed, Inc., backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT® drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced that the Israel Patent Office has issued an allowance notice for NexMed's patent application entitled, "Topical Compositions for Prostaglandin E1 Delivery."
Resident physicians' participation in a brief training program designed to increase empathy with their patients produced significant improvement in how patients perceived their interactions with the residents.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
Addicts, even those who have been abstinent for long periods of time, are often still vulnerable to their own memories of prior drug use.
› Verified 4 days ago
Robert J Brumback, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
Dr. Milford Howarth Marchant Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 S Hanover St, Baltimore, MD 21225 Phone: 410-350-8336 Fax: 410-350-7178 | |
Dr. Michelle Ghert, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 110 S Paca St Fl 6, Baltimore, MD 21201 Phone: 614-397-2721 | |
Henry R Boucher, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
John J Carbone, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3001 S Hanover St, Gruehn Bldg, Ste 502, Baltimore, MD 21225 Phone: 410-350-8300 | |
Dr. Dawn Laporte, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Rm 5210, Baltimore, MD 21287 Phone: 410-955-3134 | |
Paul C Mcafee, M.D., MBA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St Ste 655, Baltimore, MD 21218 Phone: 410-554-2175 Fax: 410-554-2917 |